Back to search

Institutes outside Greece

Epigenetic regulation in rodent primordial germ cells and preimplantation embryos

Abstract

dc:description

During the course of mammalian life the epigenome of each cell in the body responds to intra- and extracellular stimuli and it adapts and shapes its features (e.g. histone modifications, DNA methylation) accordingly. This is in contrast to the genome sequence, whichmostly remains constant throughout life and it is almost identical in every cell of the body. Nevertheless, the coordinated functions of the genome and the epigenome will guide the unique gene expression program of each cell type, which will eventually define its functional identity during development. In this thesis I focused on several major epigenetic reorganization events that take place during early preimplantation rodent (mouse and rat) development and also during the course of gametogenesis. One of the epigenetic changes that occur in the early life of the mouse concerns solely the female mouse preimplantation embryo and involves regulation of the activity of its two X chromosomes. Following fertilization, the presence of a single X chromosome in the male embryo and of two X chromosomes in the female embryo generates a X-linked gene dosage imbalance. To establish a balance between X and autosomal gene expression, and to compensate for the X-linked gene expression dosage difference between the sexes, the female embryo silences one of its two X chromosomes through a process known as X chromosome inactivation (XCI). In murine preimplantation stages, it is always the paternal X chromosome (Xp) that is silenced and therefore this is an imprinted XCI (iXCI) mechanism. XCI is initiated by Xist, a long non-coding RNA that is transcribed from the future inactive X chromosome and covers that chromosome in cis. Interestingly enough, iXCI is not conserved in all mammalian species. For example, in human preimplantation embryos XIST upregulation takes place at the blastocyst stage from both parental X chromosomes and X-linked dosage compensation between the two sexes is achieved by lowering expression levels of the X-linked genes in females from both X chromosomes at the same time, rather than shutting down completely one X chromosome. This finding indicates that iXCI may be a feature of the mouse preimplantation embryo solely and underscores the necessity of characterizing XCI in other rodent species. As the mouse embryo develops, iXCI is reversed in the inner cell mass (ICM) of the blastocyst around embryonic day 4.5 (E4.5). This X reactivation is then again followed by XCI at approximately E5.5 in the epiblast cells. This time though, XCI is random, meaning that both parental X chromosomes have equal chances to get inactivated. The epiblast cells will give rise to the embryo proper. Once one X chromosome gets silenced in an epiblast cell de novo, its silenced state will be clonally propagated in the subsequent divisions. At around E6.5 of mouse embryo development, the formation of the germline initiates in the dorsal epiblast through signalling emerging from the proximal extra-embryonic ectoderm. At this point the emerging primordial germ cells (PGCs) hold the same epigenetic signature and gene expression profile as the surrounding epiblast cells, which are destined to become somatic in nature. While developing further, genome wide reprogramming takes place in PGCs. This includes global alterations in histone modifications e.g. loss of H3K9me2, enrichment of H3K27me3 and global loss of DNA methylation, including also DNA methylation marking imprinted genes. All these alterations will lead to silencing of the somatic gene expression program, and to the activation of a germline one. However, during this reprogramming wave, the pericentromeres may need to retain their main epigenetic characteristics, especially since loss of histone modifications on these regions is linked to genetic aberrations. The inactive X chromosome does not escape from the genome wide epigenetic resetting in the germline and it is reactivated in the female PGCs. At around E13.5-E14.5, female PGCs enter meiosis, where both X chromosomes within the developing oocyte remain active. In addition, during oogenesis the X chromosome acquires an imprint, which will ensure that the maternal X chromosome will remain active during early mouse preimplantation development. In male E13.5-E14.5 embryos, the PGCs enter mitotic arrest. Mitosis is resumed shortly after birth and male germ cells initiate spermatogenesis. As in females, male germ cells also enter meiosis, where homologous chromosomes pair and exchange genetic information to eventually produce genetically unique haploid gametes. The pairing of the X and Y sex chromosomes is challenging since the sex chromosomes are highly non-homologous and only synapse in a small homologous region called pseudoautosomal region (PAR). The extensive asynapsis between the X and Y chromosomes is associated with their transcriptional inactivation in a process called Meiotic Sex Chromosome Inactivation (MSCI). This transcriptional inactivation largely persists (although some genes arereactivated) one stage later, in the haploid round spermatids and is now termed as Post-meiotic Sex Chromosome Repression (PSCR). Later on, during spermiogenesis, the vast majority of histones in the developing sperm is replaced by protamines, that will facilitatethe further compaction of the sperm genome into the small sperm nucleus. Following fertilization, the protamines are removed and replaced with unmodified histones provided by the oocyte. Current evidence suggests, that the Xp Xist gene becomes active at the 2-cell stage, concomitant with zygotic genome activation (ZGA). However, the possibility that certain epigenetic marks related to MSCI and PSCR persist on the sperm genome, and may have an impact on iXCI after fertilisation, cannot be excluded. All the above-mentioned reprogramming events must be tightly coordinated and controlled, since defects in the cascade of steps comprising these events is linked to embryonic lethality or infertility. In this thesis I have focused on characterising and understanding epigenetic phenomena taking place during early rodent preimplantation and PGC development. Therefore, in Chapter 1 I provide a detailed theoretical overview of the epigenetic phenomena examined in this thesis.In Chapter 2, we sought to examine the impact of the paternal epigenome on mouse iXCI. For this purpose, we made use of the round spermatid injection (ROSI) technology, and we injected round spermatids deficient for Xist (XpΔXist) and which already carry a largely transcriptionally inactive X chromosome (due to PSCR), enriched with silencing histone marks such as H3K9me3. We speculated that by bypassing the histone-to-protamine and protamine-to-histone transitions through ROSI and by injecting an alreadypre-inactivated Xp we might be able to establish Xp inactivation, in the absence of a functional paternal Xist. At the same time we hypothesized that we would rescue female embryonic lethality that is normally observed when sperm lacking functional Xist is used forfertilisation. Indeed, by performing ROSI with ΔXist round spermatids we were able to rescue the embryonic lethality of XpXistXm female embryos. Surprisingly though, RNA-DNA FISH experiments for the maternal wild type and the paternal mutated Xist gene and RNA revealed that the rescue was not mediated by an Xist independent inactivation of Xp, but rather by inactivating the maternal X chromosome (Xm) through maternally provided Xist mediated silencing. Initiation of Xm inactivation in XpΔXistΧm ROSI derived female embryos takes place later (~morula stage) compared to Xp inactivation in wild type embryos derived either by natural mating or by injecting wild type round spermatids (~4-cell stage), and silencing marks (H3K27me3) are established in the blastocyst rather than during the morula stage. We found that an XCI trans-activator named RNF12 is present in high levels in male and female embryos, when performing ROSI. However, since we never observed Xist expression in male embryos following ROSI, we speculate that additional still unknown factors act together with RNF12 to mediate to silencing of Xm, in the presence of XpΔXist. This then eventually allows survival of these female embryos. Interestingly, rescuing was not achieved when CAS/EiJ spermatids were used instead of C57BL6, indicating that critical factors contributing to the rescuing may not be (sufficiently) expressed in the CAS/EiJ round spermatids. Overall, our data suggest that the correct regulation of expression of X-linked trans-activators of XCI from possibly both X chromosomes is of critical importance in the establishment of XCI in mouse. Future experimentation may provide evidence on the identity of such XCI trans-activators. Going one step later in development, in Chapter 3 we focused on the epigenetic signature of pericentric heterochromatin during PGC development. In this study, we used different fixation and sample preparation methods to carefully examine the epigenetic state of pericentric heterochromatin during PGC development. Our results indicated that pericentric heterochromatin maintains its epigenetic marks throughout PGC development. However, we did notice that under a certain condition the original observations by others - that pericentric heterochromatin loses its epigenetic identity at E11.5 mouse embryo development - could also be reproduced. The data we obtained nicely illustrated the necessity of evaluating results of different experimental approaches in order to reach valid conclusions. In addition, analysis by immunofluorescence with specific markers of pericentromeric clustering (chromocenter formation) revealed that pericentromeres did not cluster together in a similar fashion as in the surrounding somatic cells, but they mainly remained as individual entities within the E10.5-E13.5 PGC nuclei. This individualisation was not accompanied by transcriptional activation of pericentric transcripts (major satellites), and might reflect alterations in the organisation and structure of PGC pericentromeres. Lastly, we observed higher accumulation of the chromatin remodeller ATRX on the pericentromeres of E11.5 PGCs compared to the surrounding soma of the same developmental stage. In the future it would be interesting to examine what is the exact function of the elevated ATRX accumulation in the pericentromeres of E11.5 PGCs, and when the dissociation of the chromocenters initiates in the germline. In Chapter 4 we established a robust in vitro differentiation strategy in order to examine XCI in rat differentiating stem cells (ESCs). Studying XCI in a species other than the mouse may provide valuable information about the conserved aspects of iXCI in rodents. This is particularly important, especially since iXCI does not seem to be conserved in all mammalian species e.g. human. With the use of our in vitro strategy, we were able to demonstrate that the process of XCI in the female rat cell lines initiates at ~ day 2 of differentiation by accumulation of Xist transcripts on one of the two X chromosomes. X-linked gene silencing through H3K27me3 enrichment on the same X chromosome also rapidly follows the Xist accumulation. Importantly, by overexpressing factors known to be decisive for XCI in mouse (REX1 and RNF12), in rESCs we observed that certain XCI regulation aspects (REX1-RNF12 axis) are indeed conserved between mouse and rat. In Chapter 5 we established a powerful and rapid DNA-RNA FISH protocol, which enables the simultaneous detection of DNA and RNA molecules in mouse pre-implantation embryos, without compromising the sample’s quality. This was achieved by incorporating and adapting steps used in DNA FISH such as sample incubation in HCl solution in our RNA FISH protocol common. The use of our DNA-RNA FISH protocol may be a valuable tool not only in basic science, for example when studying different XCI aspects in the early embryo, but also in diagnostics, since it could be potentially adapted and applied to any other type of material (e.g. cultured cells, patient tissue samples) where both nascent RNA transcripts (Xist or others) and genomic positions need to be detected.To conclude, in Chapter 6 I have discussed the results obtained during the course of my Ph.D. study in light of the current knowledge concerning the epigenetic phenomena presented and studied in this thesis. Finally, I provide suggestions for future research directions, in line with experimental restrictions but also possibilities when studying low abundance-cells, such as PGCs or early embryos, that will facilitate obtaining a better overview of the examined epigenetic phenomena described here.

Degree

thesis:*
Grantor dc:publisher
Institutes outside Greece
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Magaraki, Aristea Maria
  • Μαγαράκη, Αριστέα-Μαρία

Subjects

dc:subject × 10

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61043

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Magaraki, Aristea Maria; Μαγαράκη, Αριστέα-Μαρία. Epigenetic regulation in rodent primordial germ cells and preimplantation embryos. Institutes outside Greece, 2017. http://hdl.handle.net/10442/hedi/61043